Cardiac Graft Versus Host Disease: A Rare or Underrecognized Pathology?

Area of Science:

• Hematology
• Immunology
• Cardiology

Background:

• Allogeneic hematopoietic stem cell transplantation (HSCT) offers curative potential for hematologic and immunologic disorders.
• HSCT is associated with significant toxicities, including graft-versus-host disease (GVHD) and cardiovascular disease, leading to morbidity and mortality.
• Cardiac involvement in GVHD is infrequently reported, despite GVHD potentially affecting any organ system.

Purpose of the Study:

• To review the existing literature on cardiac GVHD.
• To discuss the pathophysiology of cardiac GVHD.
• To outline current and potential therapeutic approaches for cardiac GVHD.

Main Methods:

• Comprehensive literature search of scientific databases.
• Review and synthesis of studies reporting cardiac manifestations of GVHD.
• Analysis of proposed mechanisms and treatment strategies for cardiac GVHD.

Main Results:

• Cardiac GVHD is a rare but potentially severe complication following allogeneic HSCT.
• Pathophysiological mechanisms may involve direct immune attack on cardiac tissues or indirect effects.
• Limited data exists on effective therapeutic interventions, highlighting a gap in clinical management.

Conclusions:

• Cardiac GVHD represents an under-recognized complication of allogeneic HSCT.
• Further research is crucial to elucidate its pathophysiology and develop targeted therapies.
• Improved understanding and management strategies are needed to mitigate cardiac morbidity and mortality in HSCT recipients.